Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Aug;14(2):228–233. doi: 10.1128/aac.14.2.228

UK-18892, a New Aminoglycoside: An In Vitro Study

R Wise 1, J M Andrews 1
PMCID: PMC352438  PMID: 100050

Abstract

UK-18892 is a new aminoglycoside antibiotic, a derivative of kanamycin A structurally related to amikacin. It was found to be active against a wide range of pathogenic bacteria, including many gentamicin-resistant strains. The spectrum and degree of activity of UK-18892 were similar to those of amikacin, and differences were relatively minor. UK-18892 was about twice as active as amikacin against gentamicin-susceptible strains of Pseudomonas aeruginosa. Both amikacin and UK-18892 were equally active against gentamicin-resistant strains of P. aeruginosa. There were no appreciable differences in the activity of UK-18892 and amikacin against Enterobacteriaceae and Staphylococcus aureus. Cross-resistance between these two antimicrobials was also apparent.

Full text

PDF
228

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benveniste R., Davies J. Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor. Biochemistry. 1971 May 11;10(10):1787–1796. doi: 10.1021/bi00786a009. [DOI] [PubMed] [Google Scholar]
  2. Kawaguchi H. Discovery, chemistry, and activity of amikacin. J Infect Dis. 1976 Nov;134(Suppl):S242–S248. doi: 10.1093/infdis/135.supplement_2.s242. [DOI] [PubMed] [Google Scholar]
  3. Price K. E., DeFuria M. D., Pursiano T. A. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates. J Infect Dis. 1976 Nov;134(Suppl):S249–S261. doi: 10.1093/infdis/135.supplement_2.s249. [DOI] [PubMed] [Google Scholar]
  4. Richardson K., Jevons S., Moore J. W., Ross B. C., Wright J. R. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives. J Antibiot (Tokyo) 1977 Oct;30(10):843–846. doi: 10.7164/antibiotics.30.843. [DOI] [PubMed] [Google Scholar]
  5. Sharp P. M., Saenz C. A., Martin R. R. Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections. Antimicrob Agents Chemother. 1974 May;5(5):435–438. doi: 10.1128/aac.5.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Young L. S., Hewitt W. L. Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus. Antimicrob Agents Chemother. 1973 Dec;4(6):617–625. doi: 10.1128/aac.4.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES